BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20215547)

  • 1. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
    Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
    Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
    Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HYAL1 overexpression is correlated with the malignant behavior of human breast cancer.
    Tan JX; Wang XY; Li HY; Su XL; Wang L; Ran L; Zheng K; Ren GS
    Int J Cancer; 2011 Mar; 128(6):1303-15. PubMed ID: 20473947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway.
    Bao JJ; Le XF; Wang RY; Yuan J; Wang L; Atkinson EN; LaPushin R; Andreeff M; Fang B; Yu Y; Bast RC
    Cancer Res; 2002 Dec; 62(24):7264-72. PubMed ID: 12499268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer.
    Hu F; Meng X; Tong Q; Liang L; Xiang R; Zhu T; Yang S
    Biochim Biophys Acta; 2013 Dec; 1832(12):2379-90. PubMed ID: 24012720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
    Kuo PL; Chen CY; Hsu YL
    Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEA-15 facilitates EGFR dephosphorylation via ERK sequestration at increased ER-PM contacts in TNBC cells.
    Shin M; Lee KE; Yang EG; Jeon H; Song HK
    FEBS Lett; 2015 Apr; 589(9):1033-9. PubMed ID: 25796184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.
    Liu ZB; Hou YF; Zhu J; Hu DL; Jin W; Ou ZL; Di GH; Wu J; Shen ZZ; Shao ZM
    Oncogene; 2010 May; 29(20):2996-3009. PubMed ID: 20228837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer.
    Xie X; Tang H; Pengliu ; Kong Y; Wu M; Xiao X; Yang L; Gao J; Wei W; Lee J; Bartholomeusz C; Ueno NT; Xie X
    Cancer Lett; 2015 Jan; 356(2 Pt B):374-381. PubMed ID: 25304382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Anticancer Activity of Pterostilbene Against Three Subtypes of Human Breast Cancer Cells.
    Wakimoto R; Ono M; Takeshima M; Higuchi T; Nakano S
    Anticancer Res; 2017 Nov; 37(11):6153-6159. PubMed ID: 29061796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells.
    Shu ST; Sugimoto Y; Liu S; Chang HL; Ye W; Wang LS; Huang YW; Yan P; Lin YC
    Anticancer Res; 2010 Jun; 30(6):1937-46. PubMed ID: 20651337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
    Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
    Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.
    Glading A; Koziol JA; Krueger J; Ginsberg MH
    Cancer Res; 2007 Feb; 67(4):1536-44. PubMed ID: 17308092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
    Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
    Guix M; Granja Nde M; Meszoely I; Adkins TB; Wieman BM; Frierson KE; Sanchez V; Sanders ME; Grau AM; Mayer IA; Pestano G; Shyr Y; Muthuswamy S; Calvo B; Krontiras H; Krop IE; Kelley MC; Arteaga CL
    J Clin Oncol; 2008 Feb; 26(6):897-906. PubMed ID: 18180460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
    Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
    Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.